Obstetrics and Gynecology

Medicine & Life Sciences

1. Type 1 Diabetes Mellitus 100%
2. Leiomyoma 88%
3. Genes 61%
4. Lung 57%
5. Nitric Oxide 52%
6. Pregnancy 50%
7. Papillomavirus Vaccines 47%
8. Pulmonary Hypertension 46%
9. Polycystic Ovary Syndrome 46%
10. Autoimmunity 42%
11. Fetal Heart Rate 39%
12. Proteins 39%
13. Nitric Oxide Synthase Type III 38%
14. Infertility 38%
15. Autoantibodies 37%
16. Colposcopy 35%
17. Mutation 34%
18. Uterine Cervical Neoplasms 33%
19. Nitric Oxide Synthase 31%
20. Endothelial Cells 30%
21. Neoplasms 29%
22. Papanicolaou Test 28%
23. Hypogonadism 28%
24. Mothers 27%
25. Endothelin-1 25%
26. Therapeutics 25%
27. Kallmann Syndrome 25%
28. Ovarian Neoplasms 24%
29. Smooth Muscle Myocytes 23%
30. Human papillomavirus 6 23%
31. Child 23%
32. Superoxides 23%
33. Estrogens 22%
34. Vaccines 22%
35. Hypoxia 22%
36. Population 21%
37. Cervical Intraepithelial Neoplasia 21%
38. Genetic Therapy 20%
39. Gene Expression 20%
40. Adenoviridae 20%
41. Inbred NOD Mouse 19%
42. Serum 19%
43. Phenotype 19%
44. Pulmonary Artery 19%
45. Genotype 18%
46. Placebos 18%
47. Fertility 18%
48. Oxidative Stress 18%
49. Nitric Oxide Synthase Type I 18%
50. Biomarkers 18%
51. Fetus 17%
52. Live Birth 17%
53. Papillomavirus Infections 17%
54. Estrogen Receptors 17%
55. Endometriosis 17%
56. Gonadotropin-Releasing Hormone 17%
57. Cervix Uteri 17%
58. Apoptosis 16%
59. Fetal Movement 16%
60. Growth 16%
61. Messenger RNA 16%
62. Ovulation Induction 16%
63. Amniotic Fluid 16%
64. Acute Lung Injury 16%
65. Single Nucleotide Polymorphism 16%
66. Infections 16%
67. Reactive Oxygen Species 16%
68. Randomized Controlled Trials 16%
69. Human papillomavirus 11 15%
70. Cell Proliferation 15%
71. Organism Cloning 14%
72. DNA 14%
73. Enzymes 14%
74. Follicle Stimulating Hormone 14%
75. Incidence 14%
76. Celiac Disease 13%
77. Testosterone 13%
78. Gonadotropins 13%
79. Catechol O-Methyltransferase 13%
80. Phosphorylation 13%
81. Vascular Remodeling 13%
82. Virus-Like Particle Vaccines 12%
83. Oxidoreductases 12%
84. Intellectual Disability 12%
85. Clinical Trials 12%
86. Complementary DNA 12%
87. Ovarian Epithelial Carcinoma 12%
88. Obstetrics 12%
89. Vitamin D 12%
90. N,N-dimethylarginine 12%
91. Proteomics 12%
92. Blood Vessels 11%
93. Survival 11%
94. Cell Line 11%
95. Genitalia 11%
96. Confidence Intervals 11%
97. Insulin 11%
98. Myometrium 11%
99. Peroxynitrous Acid 11%